» Articles » PMID: 37520775

Emerging Strategies in 3D Culture Models for Hematological Cancers

Overview
Journal Hemasphere
Publisher Wiley
Specialty Hematology
Date 2023 Jul 31
PMID 37520775
Authors
Affiliations
Soon will be listed here.
Abstract

In vitro cell cultures are fundamental and necessary tools in cancer research and personalized drug discovery. Currently, most cells are cultured using two-dimensional (2D) methods, and drug testing is mainly performed in animal models. However, new and improved methods that implement three-dimensional (3D) cell-culturing techniques provide compelling evidence that more advanced experiments can be performed, yielding valuable new insights. In 3D cell-culture experiments, the cell environment can be manipulated to mimic the complexity and dynamicity of the human tissue microenvironment, possibly leading to more accurate representations of cell-to-cell interactions, tumor biology, and predictions of drug response. The 3D cell cultures can also potentially provide alternative ways to study hematological cancers and are expected to eventually bridge the gap between 2D cell culture and animal models. The present review provides an overview of the complexity of the lymphoid microenvironment and a summary of the currently used 3D models that aim at recreating it for hematological cancer research. We here dissect the differences and challenges between, and potential advantages of, different culture methods and present our vision of the most promising future strategies in the hematological field.

Citing Articles

In Vitro 3D Models of Haematological Malignancies: Current Trends and the Road Ahead?.

Mattioda C, Voena C, Ciardelli G, Mattu C Cells. 2025; 14(1.

PMID: 39791739 PMC: 11720277. DOI: 10.3390/cells14010038.


Exploring oncology treatment strategies with tyrosine kinase inhibitors through advanced 3D models (Review).

Isinelli G, Failla S, Plebani R, Prete A Med Int (Lond). 2025; 5(2):13.

PMID: 39790707 PMC: 11707505. DOI: 10.3892/mi.2024.212.


Three-dimensional models: from cell culture to Patient-Derived Organoid and its application to future liposarcoma research.

Tahara S, Rentsch S, DE Faria F, Sarchet P, Karna R, Calore F Oncol Res. 2024; 33(1):1-13.

PMID: 39735679 PMC: 11671414. DOI: 10.32604/or.2024.053635.


Improving tumor microenvironment assessment in chip systems through next-generation technology integration.

Gaebler D, Hachey S, Hughes C Front Bioeng Biotechnol. 2024; 12:1462293.

PMID: 39386043 PMC: 11461320. DOI: 10.3389/fbioe.2024.1462293.

References
1.
Baker B, Chen C . Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci. 2012; 125(Pt 13):3015-24. PMC: 3434846. DOI: 10.1242/jcs.079509. View

2.
Di Maggio N, Piccinini E, Jaworski M, Trumpp A, Wendt D, Martin I . Toward modeling the bone marrow niche using scaffold-based 3D culture systems. Biomaterials. 2010; 32(2):321-9. DOI: 10.1016/j.biomaterials.2010.09.041. View

3.
Spelat R, Ferro F, Contessotto P, Warren N, Marsico G, Armes S . A worm gel-based 3D model to elucidate the paracrine interaction between multiple myeloma and mesenchymal stem cells. Mater Today Bio. 2020; 5:100040. PMC: 7083757. DOI: 10.1016/j.mtbio.2019.100040. View

4.
Kotha S, Hayes B, Phong K, Redd M, Bomsztyk K, Ramakrishnan A . Engineering a multicellular vascular niche to model hematopoietic cell trafficking. Stem Cell Res Ther. 2018; 9(1):77. PMC: 5865379. DOI: 10.1186/s13287-018-0808-2. View

5.
Cupedo T, Stroock A, Coles M . Application of tissue engineering to the immune system: development of artificial lymph nodes. Front Immunol. 2012; 3:343. PMC: 3499788. DOI: 10.3389/fimmu.2012.00343. View